“Vical Inc. said its genital herpes vaccine didn’t meet the primary endpoint in a Phase 1/Phase 2 clinical trial.” (1) – WSJ.com  Herpes vaccines have been in the news a lot recently. You see, the public WANTS an effective herpes Read More …